[Pharmacology and clinical effects of acid determination in ulcer hemorrhage].
Schepp
W
W
II. Medizinische Klinik und Poliklinik, Klinikum Rechts der Isar, München.
D000897:Anti-Ulcer Agents / Q000097:blood / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D004381:Duodenal Ulcer / Q000097:blood / Q000188:drug therapy*; D005745:Gastric Acidity Determination; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000097:blood / Q000188:drug therapy*; D011453:Prostaglandins / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D013004:Somatostatin / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000097:blood / Q000188:drug therapy*
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D011453:Prostaglandins; D054328:Proton Pump Inhibitors; D013004:Somatostatin
Pharmakologie und klinische Effekte der Säurehemmung bei der Ulkusblutung.